CSIMarket Company Name, Ticker, Suppliers, else..
 
23andme Holding Co  (ME)
 

ME's Market share relative to its competitors, as of Q1 2025

As of Q1 2025 (Revenue in Millions of $)

Date modified: 2026-05-28T05:56:15+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months
Q1 2025		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE
A Quarter Before
Q4 2024
23andme Holding Co 174.02 0.04% 0.02 % 0.04 %
Apple Inc 451,442.00 97.08% 97.18% 97.22%
Lineage Inc 6,510.95 1.40% 1.15% 1.18%
Illumina Inc 4,393.00 0.94% 1.03% 0.95%
Myriad Genetics Inc 828.00 0.18% 0.17% 0.17%
Bridgebio Pharma Inc 579.96 0.12% 0.22% 0.17%
16 more competitors available

Sign in to see all competitors for 23andme Holding Co.

Sign In Create Free Account



ME's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
23andme Holding Co 14.71% 18.48% 6.94 % 12.40 %
Bridgebio Pharma Inc 49.02% 49.10% 68.91% 52.12%
Anaptysbio Inc 19.64% 22.94% 7.23% 29.01%
Tango Therapeutics Inc 5.62% 2.38% 0.00% 0.00%
Verve Therapeutics Inc 5.04% 3.16% 9.33% 3.51%
Precigen Inc 2.67% 0.95% 6.58% 1.22%
9 more companies available

Sign in to see all industry competitors for 23andme Holding Co.

Sign In Create Free Account



ME's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
23andme Holding Co 2.47% 2.80% 1.31 % 2.53 %
Illumina Inc 62.30% 64.35% 61.67% 59.61%
Myriad Genetics Inc 11.74% 12.20% 10.15% 10.91%
Bridgebio Pharma Inc 8.23% 7.44% 12.97% 10.63%
Veracyte Inc 7.32% 7.25% 8.00% 7.33%
Anaptysbio Inc 3.30% 3.48% 1.36% 5.91%
14 more companies available

Sign in to see all sector competitors for 23andme Holding Co.

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of 23andme Holding Co's market divisions, geographic dispersion, segments, products, and services, visit 23andme Holding Co's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.